Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
04 2022
Historique:
received: 12 11 2021
revised: 17 02 2022
accepted: 18 02 2022
pubmed: 27 2 2022
medline: 27 4 2022
entrez: 26 2 2022
Statut: ppublish

Résumé

The polysaccharide capsule of fungal pathogen Cryptococcus neoformans is a critical virulence factor that has historically evaded complete characterization. Cryptococcal polysaccharides are known to either remain attached to the cell as capsular polysaccharides (CPSs) or to be shed into the extracellular space as exopolysaccharides (EPSs). While many studies have examined the properties of EPS, far less is known about CPS. In this work, we detail the development of new physical and enzymatic methods for the isolation of CPS which can be used to explore the architecture of the capsule and isolated capsular material. We show that sonication or Glucanex enzyme cocktail digestion yields soluble CPS preparations, while use of a French pressure cell press or Glucanex digestion followed by cell disruption removed the capsule and produced cell wall-associated polysaccharide aggregates that we call "capsule ghosts", implying an inherent organization that allows the CPS to exist independent of the cell wall surface. Since sonication and Glucanex digestion were noncytotoxic, it was also possible to observe the cryptococcal cells rebuilding their capsule, revealing the presence of reducing end glycans throughout the capsule. Finally, analysis of dimethyl sulfoxide-extracted and sonicated CPS preparations revealed the conservation of previously identified glucuronoxylomannan motifs only in the sonicated CPS. Together, these observations provide new insights into capsule architecture and synthesis, consistent with a model in which the capsule is assembled from the cell wall outward using smaller polymers, which are then compiled into larger ones.

Identifiants

pubmed: 35218774
pii: S0021-9258(22)00209-5
doi: 10.1016/j.jbc.2022.101769
pmc: PMC8942833
pii:
doi:

Substances chimiques

Polysaccharides 0
Virulence Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101769

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI052733
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI152078
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI138953
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007417
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059842
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have no conflicts of interest to report.

Auteurs

Maggie P Wear (MP)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: mwear1@jhu.edu.

Ella Jacobs (E)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Siqing Wang (S)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Scott A McConnell (SA)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Anthony Bowen (A)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Camilla Strother (C)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Radames J B Cordero (RJB)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Conor J Crawford (CJ)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Arturo Casadevall (A)

W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol
Animals Flax Chickens Dietary Supplements Endo-1,4-beta Xylanases

Two codependent routes lead to high-level MRSA.

Abimbola Feyisara Adedeji-Olulana, Katarzyna Wacnik, Lucia Lafage et al.
1.00
Methicillin-Resistant Staphylococcus aureus Penicillin-Binding Proteins Peptidoglycan Bacterial Proteins Anti-Bacterial Agents

Helicobacter pylori biofilm interference by N-acyl homoserine lactonases: in vitro and in silico approaches.

Vinoj Gopalakrishnan, Vaijayanthi Saravanan, Maria Infant Majula Shifani Mahendran et al.
1.00
Biofilms Helicobacter pylori Bacterial Proteins Carboxylic Ester Hydrolases Molecular Docking Simulation

Classifications MeSH